학술논문
Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.
Document Type
Academic Journal
Author
Copen CE; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Delaney KP; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Agnew-Brune C; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Berry I; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Griffin I; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Hassan R; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Oakley LP; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Wondmeneh S; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Rhodes T; DC Health, Washington, DC.; Gillani S; DC Health, Washington, DC.; Lee M; DC Health, Washington, DC.; Ashley P; DC Health, Washington, DC.; Willut C; DC Health, Washington, DC.; Mangla AT; DC Health, Washington, DC.; Waltenburg MA; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.; Jackson DA; From the Centers for Disease Control and Prevention Multinational Mpox Response, Atlanta, GA.
Source
Publisher: J B Lippincott Country of Publication: United States NLM ID: 7705941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4521 (Electronic) Linking ISSN: 01485717 NLM ISO Abbreviation: Sex Transm Dis Subsets: MEDLINE
Subject
Language
English
Abstract
Background: Over 30,000 mpox cases were reported during the 2022 mpox outbreak with many cases occurring among gay, bisexual and other men who have sex with men (MSM). Decreases in U.S. mpox cases were likely accelerated by a combination of vaccination and modifications to sexual behaviors associated with mpox virus transmission. We assessed reports of sexual behavior change among participants receiving mpox vaccination in Washington, DC.
Methods: During August to October 2022, 711 adults aged ≥18 years receiving mpox vaccination at two public health clinics in Washington, DC completed a self-administered questionnaire that asked whether sexual behaviors changed since learning about mpox. We calculated the frequency and percentages of participants reporting an increase, decrease, or no change in 4 of these behaviors by demographic, clinical, and behavioral characteristics with 95% confidence intervals.
Results: Overall, between 46% and 61% of participants reported a decrease in sexual behaviors associated with mpox virus transmission, 39% to 54% reported no change in these behaviors, and <1% reported an increase. Approximately 61% reported decreases in one-time sexual encounters (95% confidence interval [CI], 56.8%-64.7%), 54.3% reduced numbers of sex partners (95% CI, 50.4%-58.0%), 53.4% decreased sex via a dating app or sex venue (95% CI, 49.7%-58.0%), and 45.6% reported less group sex (95% CI, 40.4%-50.9%). Reported decreases in these behaviors were higher for MSM than women; in non-Hispanic Black than non-Hispanic White participants; and in participants with human immunodeficiency virus than participants without human immunodeficiency virus.
Conclusions: Most participants receiving mpox vaccination reported decreasing sexual behaviors associated with mpox virus transmission, including groups disproportionately affected by the outbreak.
Competing Interests: Conflict of Interest and Sources of Funding: None declared.
(Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)
Methods: During August to October 2022, 711 adults aged ≥18 years receiving mpox vaccination at two public health clinics in Washington, DC completed a self-administered questionnaire that asked whether sexual behaviors changed since learning about mpox. We calculated the frequency and percentages of participants reporting an increase, decrease, or no change in 4 of these behaviors by demographic, clinical, and behavioral characteristics with 95% confidence intervals.
Results: Overall, between 46% and 61% of participants reported a decrease in sexual behaviors associated with mpox virus transmission, 39% to 54% reported no change in these behaviors, and <1% reported an increase. Approximately 61% reported decreases in one-time sexual encounters (95% confidence interval [CI], 56.8%-64.7%), 54.3% reduced numbers of sex partners (95% CI, 50.4%-58.0%), 53.4% decreased sex via a dating app or sex venue (95% CI, 49.7%-58.0%), and 45.6% reported less group sex (95% CI, 40.4%-50.9%). Reported decreases in these behaviors were higher for MSM than women; in non-Hispanic Black than non-Hispanic White participants; and in participants with human immunodeficiency virus than participants without human immunodeficiency virus.
Conclusions: Most participants receiving mpox vaccination reported decreasing sexual behaviors associated with mpox virus transmission, including groups disproportionately affected by the outbreak.
Competing Interests: Conflict of Interest and Sources of Funding: None declared.
(Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)